Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

\- Olanzapine 5mg, administered once daily, during 5 days (day before chemotherapy, the D day of the chemotherapy and 3 day after chemotherapy)

\- Netupitanto 300 mg, once daily, on chemotherapy day;

\- Palonosetron 0.56 mg, once daily, on chemotherapy day;